Citation: | WEN Lu, OUYANG Hui, YUAN Hao, TIAN Jing, ZHANG Fang. Application of B-type brain natriuretic peptide in patients with acute exacerbation of chronic obstructive pulmonary disease with left ventricular ejection fraction retention[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 46-50. DOI: 10.7619/jcmp.20222662 |
To analyze the correlations of serum B-type brain natriuretic peptide (BNP) with arterial partial pressure of oxygen[pa(O2)], high-sensitivity C-reactive protein (hs-CRP), right ventricular end diastolic diameter (RVDD) and death in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and left ventricular ejection function (LVEF) preservation.
The data of 150 AECOPD patients with LVEF preservation were retrospectively analyzed. According to the serum BNP level, they were divided into group A (BNP ≤ 100 pg/mL, n=82), group B (BNP>100 pg/mL to 400 pg/mL, n=45) and group C (BNP>400 pg/mL, n=23). The pa(O2), BNP, hs-CRP and RVDD were compared among the three groups after admission. The correlations of BNP with pa(O2), hs-CRP as well as RVDD were analyzed; predictors of death within 1 year were analyzed by Logistic regression. The 1 year mortality risk ratio (RR) of the 3 groups was analyzed.
The pa(O2) in group B and group C was significantly lower than that in group A, and BNP, hs-CRP and RVDD were higher than those in group A (P < 0.05). BNP and hs-CRP in group C were significantly higher than those in group B (P < 0.05). Correlation analysis showed that BNP was negatively correlated with pa(O2) (r=-0.385, P < 0.001), but positively correlated with hs-CRP and RVDD (r=0.664, 0.388, P < 0.001). Within 1 year, the RR and 95%CI of group C with group A and group B were 1.303(1.019 to 1.668) and 1.263(0.978 to 1.630), respectively, and the differences were statistically significant (P < 0.05). BNP was an independent predicting factor for death within 1 year (P < 0.05).
The elevated BNP level in AECOPD patients with LVEF preservation is associated with decreased pa(O2) level, increased hs-CRP, and increased RVDD. Serum BNP is a sensitive indicator for assessing the condition of AECOPD and death.
[1] |
YU S S, ZHANG J, FANG Q H, et al. Blood eosinophil levels and prognosis of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Am J Med Sci, 2021, 362(1): 56-62. doi: 10.1016/j.amjms.2021.02.013
|
[2] |
MAISE A, MUELLER C, PEACOCK W F, et al. 2008中西方BNP专家共识[J]. 中国医药导刊, 2009, 11(10): 1628-1637. doi: 10.3969/j.issn.1009-0959.2009.10.003
|
[3] |
ABROUG F, OUANES-BESBES L, NCIRI N, et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers[J]. Am J Respir Crit Care Med, 2006, 174(9): 990-996. doi: 10.1164/rccm.200603-380OC
|
[4] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会, 陈荣昌, 等. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205. doi: 10.3760/cma.j.cn112147-20210109-00031
|
[5] |
YAO C, WANG L W, SHI F, et al. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure[J]. Int J Med Sci, 2021, 18(7): 1592-1599. doi: 10.7150/ijms.52405
|
[6] |
吕骁, 张宏英, 毛雅云, 等. BNP、HCAR及D-D在慢性阻塞性肺疾病急性加重期合并Ⅱ型呼吸衰竭中的变化及与病情、预后的相关性[J]. 临床误诊误治, 2021, 34(6): 86-91. doi: 10.3969/j.issn.1002-3429.2021.06.018
|
[7] |
王宝俊, 王华, 张金莲. 慢性阻塞性肺疾病急性加重期患者血浆中肌钙蛋白Ⅰ、脑钠肽及血尿酸测定的临床意义[J]. 国际呼吸杂志, 2016, 36(16): 1225-1227. doi: 10.3760/cma.j.issn.1673-436X.2016.16.006
|
[8] |
NISHIMURA K, NISHIMURA T, ONISHI K, et al. Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2014, 9: 155-162.
|
[9] |
HAWKINS N M, KHOSLA A, VIRANI S A, et al. B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review[J]. BMC Pulm Med, 2017, 17(1): 11. doi: 10.1186/s12890-016-0345-7
|
[10] |
王煜. 慢性阻塞性肺疾病中脑钠肽水平的变化及其临床意义[J]. 陕西医学杂志, 2013, 42(1): 18-20. doi: 10.3969/j.issn.1000-7377.2013.01.005
|
[11] |
胡旭, 靳开宇, 范贤明. 慢性阻塞性肺疾病合并支气管扩张的发病机制、诊断与治疗研究进展[J]. 山东医药, 2016, 56(31): 106-108. doi: 10.3969/j.issn.1002-266X.2016.31.036
|
[12] |
廉静, 张爱菊, 张燕. 超敏C反应蛋白与扩张型心肌病患者炎症因子水平、心功能的相关性[J]. 心血管康复医学杂志, 2018, 27(6): 642-645. doi: 10.3969/j.issn.1008-0074.2018.06.07
|
[13] |
吴长东, 侯铭, 杨嵘, 等. 联合检测二维超声心动图、BNP、6MWT、MMRC对慢性阻塞性肺疾病急性加重期患者右心功能不全的诊断意义[J]. 中华肺部疾病杂志: 电子版, 2019, 12(4): 441-444. doi: 10.3877/cma.j.issn.1674-6902.2019.04.008
|
[14] |
王潇, 许爱国. 频繁急性加重的慢性阻塞性肺疾病继发肺动脉高压的危险因素分析[J]. 河南医学研究, 2020, 29(31): 5782-5785. doi: 10.3969/j.issn.1004-437X.2020.31.006
|
[15] |
MAO B, LU H W, LI M H, et al. The existence of bronchiectasis predicts worse prognosis in patients with COPD[J]. Sci Rep, 2015, 5: 10961. doi: 10.1038/srep10961
|
[16] |
PARK S Y, LEE C Y, KIM C, et al. One-year prognosis and the role of brain natriuretic peptide levels in patients with chronic cor pulmonale[J]. J Korean Med Sci, 2015, 30(4): 442-449. doi: 10.3346/jkms.2015.30.4.442
|
[17] |
赵娜, 谢才德. 血浆B型脑钠肽水平在慢性阻塞性肺疾病近远期治疗预后评估中的价值[J]. 临床肺科杂志, 2017, 22(3): 427-430. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFK201703011.htm
|
[18] |
谢小兵, 高云, 牛灵, 等. 急性加重期和稳定期COPD患者血清CRP、IL-6、PCT及BNP水平变化[J]. 山东医药, 2020, 60(30): 73-75. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY202030019.htm
|